免费精品视频一区二区三区学生,被3个黑人老外玩的4p,人妻精品无码中文无码一区无,添女人荫蒂全部过

首頁> 外文期刊>Biochimica et biophysica acta. Molecular basis of disease: BBA >Mutations causing neurodegenerative tauopathies
【24h】

Mutations causing neurodegenerative tauopathies

機譯:引起神經退行性變態的突變

獲取原文
獲取原文并翻譯 | 示例

摘要

Tau is the major component of the intracellular filamentous deposits that define a number of neurodegenerative diseases. They include the largely sporadic Alzheimer's disease (AD), progressive supranuclear palsy, corticobasal degeneration, Pick's disease and argyrophilic grain disease, as well as the inherited frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). For a long time, it was unclear whether the dysfunction of tau protein follows disease or whether disease follows tau dysfunction. This was resolved when mutations in Tau were found to cause FTDP-17. Currently, 32 different mutations have been identified in over 100 families. About half of the known mutations have their primary effect at the protein level. They reduce the ability of tau protein to interact with microtubules and increase its propensity to assemble into abnormal filaments. The other mutations have their primary effect at the RNA level and perturb the normal ratio of three-repeat to four-repeat tau isoforms. Where studied, this resulted in a relative overproduction of tau protein with four microtubule-binding domains in the brain. Individual Tau mutations give rise to diseases that resemble progressive supranuclear palsy, corticobasal degeneration or Pick's disease. Moreover, the H1 haplotype of Tau has been identified as a significant risk factor for progressive supranuclear palsy and corticobasal degeneration. At a practical level, the new work is leading to the production of experimental animal models that reproduce the essential molecular and cellular features of the human tauopathies, including the formation of abundant filaments made of hyperphosphorylated tau protein and nerve cell degeneration. (C) 2004 Elsevier B.V. All rights reserved.
機譯:Tau是細胞內絲狀沉積物的主要成分,其定義了許多神經退行性疾病。它們包括散發性的阿爾茨海默氏病(AD),進行性核上性麻痹,皮質基底變性,皮克氏病和嗜銀粒病,以及與17號染色??體相關的遺傳性額顳葉癡呆和帕金森癥(FTDP-17)。長期以來,尚不清楚tau蛋白的功能障礙是疾病引起的還是疾病是tau功能障礙引起的。當發現Tau中的突變引起FTDP-17時,此問題得以解決。目前,已在100多個家庭中鑒定出32種不同的突變。大約一半的已知突變在蛋白質水平上具有主要作用。它們降低了tau蛋白與微管相互作用的能力,并增加了其組裝成異常細絲的傾向。其他突變在RNA水平上具有其主要作用,并且會擾亂三重復與四重復tau亞型的正常比例。在研究中,這導致腦中具有四個微管結合結構域的tau蛋白相對過量生產。個別的Tau突變會引起類似于進行性核上性麻痹,皮質基底變性或Pick病的疾病。此外,已將Tau的H1單倍型鑒定為進行性核上性麻痹和皮質基底變性的重要危險因素。從實用的角度來看,這項新工作正在導致產生實驗動物模型,這些動物模型可再現人tauopathies的基本分子和細胞特征,包括形成由高磷酸化tau蛋白制成的豐富細絲和神經細胞變性。 (C)2004 Elsevier B.V.保留所有權利。

著錄項

相似文獻

  • 外文文獻
  • 中文文獻
  • 專利
獲取原文

客服郵箱:kefu@zhangqiaokeyan.com

京公網安備:11010802029741號 ICP備案號:京ICP備15016152號-6 六維聯合信息科技 (北京) 有限公司?版權所有
  • 客服微信

  • 服務號

主站蜘蛛池模板: 雅安市| 阳新县| 盐城市| 宿州市| 阿坝县| 高要市| 富宁县| 勃利县| 沙田区| 桃园县| 高邮市| 南丰县| 蒙自县| 剑阁县| 元朗区| 新源县| 武强县| 湖口县| 怀远县| 板桥市| 建德市| 龙里县| 铜山县| 宁乡县| 广汉市| 建瓯市| 凤庆县| 牡丹江市| 亚东县| 肃北| 湟中县| 桐城市| 光泽县| 宝应县| 临泉县| 辉县市| 安顺市| 全椒县| 龙州县| 鞍山市| 宁国市|